Cervical maturation using mifepristone in women with normal pregnancies at or beyond term.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
May 2020
Historique:
received: 07 01 2020
revised: 05 03 2020
accepted: 06 03 2020
pubmed: 18 3 2020
medline: 4 2 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

The aim of our study was to evaluate the efficacy and safety of oral mifepristone use for cervical ripening and the initiation of labor in women with normal pregnancies at or beyond term. We conducted a monocentric, prospective, comparative study on the induction of labor in women with an unfavorable cervix after 37 or more weeks of gestation in the Franck Joly Hospital, French Guiana. The immediate induction of labor by mifepristone was compared to expectant management and the induction of labor with routine cervical ripening agents during two consecutive periods. During the first period, patients received mifepristone (600 mg orally at the moment of enrollment) and were evaluated after 48 h. In the second period, patients did not receive any drugs and were evaluated after 48 h of expectant management. Spontaneous labor or a Bishop Score ≥6 within 48 h of mifepristone administration. enrollment-induction to delivery interval, rate of failed induction, doses of prostaglandin used, mode of delivery, requirement of oxytocin augmentation, and neonatal outcomes. This study enrolled 231 women, 108 in the first and 123 in the second period undergoing induced labor at term caused by various obstetric conditions. There were no significant differences between groups for age, body mass index, gravida, parity, the initial Bishop Score, scarred uterus, or post-term pregnancy. There were statistically significant differences between the two groups concerning spontaneous labor and/ or a Bishop Score ≥6 within 48 h (p < 10-3) and received doses of misoprostol (p = 0.01). Patients receiving mifepristone were 10 times more likely to be in labor after 48 h of inclusion (RR = 9.98, CI 95 % = [4.47-22.29]). The enrollment-induction to delivery interval was significantly shorter for the mifepristone group (p < 0.001). There were no other differences in mode of delivery, placenta abnormalities or neonatal outcomes. Mifepristone efficiently induced cervical ripening and labor initiation in women with normal pregnancies at or beyond term. It may offer an alternative method to the classic induction especially for patients seeking spontaneous labor.

Identifiants

pubmed: 32179287
pii: S0301-2115(20)30128-7
doi: 10.1016/j.ejogrb.2020.03.020
pii:
doi:

Substances chimiques

Oxytocics 0
Misoprostol 0E43V0BB57

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-62

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Najeh Hcini (N)

Department of Obstetrics & Gynaecology, Centre Hospitalier de l'Ouest Guyanais, Saint-Laurent du Maroni, French Guiana. Electronic address: hcininajeh@gmail.com.

Anne Jolivet (A)

Department of Public Health, Centre Hospitalier de l'Ouest Guyanais, Saint-Laurent du Maroni, French Guiana; INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et Santé Publique, Department of Social Epidemiology, Paris, France.

Leo Pomar (L)

Materno-foetal and Obstetrics Research Unit, Obstetric Service, Department "Femme-Mère-Enfant," University Hospital, Lausanne, Switzerland.

Ali Mchirgui (A)

Department of Obstetrics & Gynaecology, Centre Hospitalier de l'Ouest Guyanais, Saint-Laurent du Maroni, French Guiana.

Fatma Maamri (F)

Department of Obstetrics & Gynaecology, Centre Hospitalier de l'Ouest Guyanais, Saint-Laurent du Maroni, French Guiana.

Youssef Elcadhi (Y)

Department of Obstetrics & Gynaecology, Centre Hospitalier de l'Ouest Guyanais, Saint-Laurent du Maroni, French Guiana.

Veronique Lambert (V)

Department of Obstetrics & Gynaecology, Centre Hospitalier de l'Ouest Guyanais, Saint-Laurent du Maroni, French Guiana.

Gabriel Carles (G)

Department of Obstetrics & Gynaecology, Centre Hospitalier de l'Ouest Guyanais, Saint-Laurent du Maroni, French Guiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH